BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27450902)

  • 1. Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.
    Paholak HJ; Stevers NO; Chen H; Burnett JP; He M; Korkaya H; McDermott SP; Deol Y; Clouthier SG; Luther T; Li Q; Wicha MS; Sun D
    Biomaterials; 2016 Oct; 104():145-57. PubMed ID: 27450902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy.
    Burke AR; Singh RN; Carroll DL; Wood JC; D'Agostino RB; Ajayan PM; Torti FM; Torti SV
    Biomaterials; 2012 Apr; 33(10):2961-70. PubMed ID: 22245557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
    Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
    Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model.
    Zhou M; Zhao J; Tian M; Song S; Zhang R; Gupta S; Tan D; Shen H; Ferrari M; Li C
    Nanoscale; 2015 Dec; 7(46):19438-47. PubMed ID: 26376843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
    Kamble D; Mahajan M; Dhat R; Sitasawad S
    Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
    Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
    Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
    Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
    Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.
    Kim SH; Sehrawat A; Singh SV
    Cancer Prev Res (Phila); 2013 Aug; 6(8):782-90. PubMed ID: 23661606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor ablation using novel photothermal Na
    Jie S; Guo X; Ouyang Z
    Int J Nanomedicine; 2019; 14():7353-7362. PubMed ID: 31571856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells.
    Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG
    Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
    Liu S; Cong Y; Wang D; Sun Y; Deng L; Liu Y; Martin-Trevino R; Shang L; McDermott SP; Landis MD; Hong S; Adams A; D'Angelo R; Ginestier C; Charafe-Jauffret E; Clouthier SG; Birnbaum D; Wong ST; Zhan M; Chang JC; Wicha MS
    Stem Cell Reports; 2014 Jan; 2(1):78-91. PubMed ID: 24511467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.
    Fritz AJ; Hong D; Boyd J; Kost J; Finstaad KH; Fitzgerald MP; Hanna S; Abuarqoub AH; Malik M; Bushweller J; Tye C; Ghule P; Gordon J; Frietze S; Zaidi SK; Lian JB; Stein JL; Stein GS
    J Cell Physiol; 2020 Oct; 235(10):7261-7272. PubMed ID: 32180230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway.
    McClements L; Yakkundi A; Papaspyropoulos A; Harrison H; Ablett MP; Jithesh PV; McKeen HD; Bennett R; Donley C; Kissenpfennig A; McIntosh S; McCarthy HO; O'Neill E; Clarke RB; Robson T
    Clin Cancer Res; 2013 Jul; 19(14):3881-93. PubMed ID: 23741069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.